Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract.

Huppert JS, Huang B, Chen C, Dawood HY, Fichorova RN.

J Infect Dis. 2013 May 1;207(9):1462-70. doi: 10.1093/infdis/jit039. Epub 2013 Jan 25.

3.

The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert.

Fichorova RN, Buck OR, Yamamoto HS, Fashemi T, Dawood HY, Fashemi B, Hayes GR, Beach DH, Takagi Y, Delaney ML, Nibert ML, Singh BN, Onderdonk AB.

Sex Transm Infect. 2013 Sep;89(6):460-6. doi: 10.1136/sextrans-2013-051052. Epub 2013 Jul 31.

4.

Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor.

Draper D, Donohoe W, Mortimer L, Heine RP.

J Infect Dis. 1998 Sep;178(3):815-9.

PMID:
9728551
5.

The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.

Fichorova RN, Chen PL, Morrison CS, Doncel GF, Mendonca K, Kwok C, Chipato T, Salata R, Mauck C.

MBio. 2015 Sep 1;6(5):e00221-15. doi: 10.1128/mBio.00221-15.

6.

The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).

Nikolaitchouk N, Andersch B, Falsen E, Str├Âmbeck L, Mattsby-Baltzer I.

APMIS. 2008 Apr;116(4):263-77. doi: 10.1111/j.1600-0463.2008.00808.x.

PMID:
18397461
7.

Human epididymis protein 4 and secretory leukocyte protease inhibitor in vaginal fluid: relation to vaginal components and bacterial composition.

Orfanelli T, Jayaram A, Doulaveris G, Forney LJ, Ledger WJ, Witkin SS.

Reprod Sci. 2014 Apr;21(4):538-42. doi: 10.1177/1933719113503416. Epub 2013 Sep 10.

PMID:
24023032
8.

Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition.

Jais M, Younes N, Chapman S, Cu-Uvin S, Ghosh M.

Am J Obstet Gynecol. 2016 Sep;215(3):324.e1-324.e10. doi: 10.1016/j.ajog.2016.03.041. Epub 2016 Mar 26.

PMID:
27026477
9.

Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens.

Huppert JS, Batteiger BE, Braslins P, Feldman JA, Hobbs MM, Sankey HZ, Sena AC, Wendel KA.

J Clin Microbiol. 2005 Feb;43(2):684-7.

10.

Trichomonas vaginalis infection induces vaginal CD4+ T-cell infiltration in a mouse model: a vaccine strategy to reduce vaginal infection and HIV transmission.

Smith JD, Garber GE.

J Infect Dis. 2015 Jul 15;212(2):285-93. doi: 10.1093/infdis/jiv036. Epub 2015 Jan 23.

PMID:
25616405
11.

Short communication: genital tumor growth factor-╬▓1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding.

Thakar M, Patil R, Shukre S, Bichare S, Kadam P, Khopkar P, Ghate M, Paranjape R.

AIDS Res Hum Retroviruses. 2014 Jul;30(7):648-53. doi: 10.1089/AID.2013.0030. Epub 2014 Mar 13.

PMID:
24547777
12.
13.

Preliminary studies on target antigens for the diagnosis of Trichomonas vaginalis infection.

Deng HY, Lee JC, Chou SC, Wang GR.

J Microbiol Immunol Infect. 1999 Mar;32(1):14-20.

PMID:
11561565
14.

Effects of pregnancy and bacterial vaginosis on proinflammatory cytokine and secretory leukocyte protease inhibitor concentrations in vaginal secretions.

Balkus J, Agnew K, Lawler R, Mitchell C, Hitti J.

J Pregnancy. 2010;2010:385981. doi: 10.1155/2010/385981. Epub 2010 Aug 8.

15.

Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.

Murphy K, Richardson BA, Dezzutti CS, Marrazzo J, Hillier SL, Hendrix CW, Herold BC.

Am J Reprod Immunol. 2015 Oct;74(4):313-22. doi: 10.1111/aji.12411. Epub 2015 Jun 21.

17.

Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women.

Shimoya K, Zhang Q, Temma K, Kimura T, Tsujie T, Tsutsui T, Wasada K, Kanzaki T, Koyama M, Murata Y.

Maturitas. 2006 May 20;54(2):141-8. Epub 2005 Nov 9.

PMID:
16289563
18.

Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.

Nittayananta W, Kemapunmanus M, Yangngam S, Talungchit S, Sriplung H.

J Oral Pathol Med. 2013 Mar;42(3):208-15. doi: 10.1111/jop.12023. Epub 2012 Nov 6.

19.

[Studies on ultrastructure and histochemistry of Trichomonas vaginalis adhering to vaginal mucosa of rats].

Chen WL, Chen JF, Zhong XR, Tang CR, Chen X, Lin X.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2001;19(5):287-9. Chinese.

PMID:
12572044
20.

Specific IgA response, T-cell subtype and cytokine profile in experimental intravaginal trichomoniasis.

Paintlia MK, Kaur S, Gupta I, Ganguly NK, Mahajan RC, Malla N.

Parasitol Res. 2002 Apr;88(4):338-43.

PMID:
11999021

Supplemental Content

Support Center